Regulatory Updates

FDA, EMA, TGA and global regulatory developments

#NDA018140 ×

Regulatory Updates

Sep 25, 2026•1 min read

FDA Approves Lorazepam Injectable (ATIVAN) NDA018140

The FDA granted approval for NDA018140, authorizing Lorazepam injectable (brand name ATIVAN) from Hikma Pharmaceuticals USA and Civica, Inc.